Rockwell Medical Inc (NASDAQ: RMTI), a biopharmaceutical company, announced yesterday that it has named Charlie Shiner as its new vice president, Marketing, effective immediately.
Shiner will report to Stuart Paul, president & chief executive officer of the company.
Shiner joins Rockwell Medical from Otsuka Pharmaceuticals Ltd. He most recently served as the marketing franchise leader for Otsuka's renal portfolio, where he successfully launched Otsuka's new therapeutic Jynarque and managed other key renal therapeutics. Previously, he held the roles of director and senior product manager, Digital Marketing at Otsuka America Pharmaceuticals. Earlier in his career, Shiner spent 11 years at Pfizer Inc where among other roles, he worked to identify and execute upon strategic opportunities for Pfizer's clinical treatments within hospital accounts across the United States.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business